| Ronald I Veatch, MD | |
|
4000 Johnson Rd, Steubenville, OH 43952-2300 | |
| (740) 264-8288 | |
| (740) 264-8622 |
| Full Name | Ronald I Veatch |
|---|---|
| Gender | Male |
| Speciality | Radiology - Diagnostic Radiology |
| Location | 4000 Johnson Rd, Steubenville, Ohio |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1811950652 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 35035853 (Ohio) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ronald I Veatch, MD Po Box 60, Pittsburgh, PA 15230-0060 Ph: (412) 937-5726 | Ronald I Veatch, MD 4000 Johnson Rd, Steubenville, OH 43952-2300 Ph: (740) 264-8288 |
News Archive
Johns Hopkins Kimmel Cancer Center researchers and colleagues have identified a novel drug combination therapy that could prime nonsmall cell lung cancers to respond better to immunotherapy.
Preserving sexual function was important to many men facing treatment for prostate cancer, according to a recent study by University of North Carolina Lineberger Comprehensive Cancer Center researchers. However, this preference was not strongly reflected in the treatment choices of men with low-risk prostate cancer.
Bacterin International, Inc., a developer of revolutionary bone graft material, today announced a three-year agreement to provide its biologic line of products, OsteoSponge®, OsteoSelect®, OsteoSponge SC®, OsteoWrap®, BacFast®, and OsteoLock®, to the vast Broadlane® nationwide network of hospitals and medical practices.
University of South Florida Department of Neurosurgery and Brain Repair faculty members have received a $2.6 million grant from the National Institutes of Health to investigate the potential for cells derived from human bone marrow to benefit post-stroke patients by repairing the blood-brain barrier.
Hapten Sciences, Inc., a privately held biotechnology company, announced today that it has filed an Investigational New Drug (IND) application and is now planning to initiate dosing of healthy volunteers in a first-in-human Phase 1 clinical trial of its lead product candidate, PDC-APB, a novel, first-in-class, compound in development for a new indication to prevent contact dermatitis due to exposure to poison ivy, oak, and sumac.
› Verified 7 days ago
John A Hyland, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 3204 Johnson Rd, Steubenville, OH 43952 Phone: 724-264-8700 Fax: 740-264-8796 | |
Jae M Koh, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 4000 Johnson Rd, Steubenville, OH 43952 Phone: 740-264-8287 Fax: 740-264-8622 | |
Dr. Christopher Thomas Hunnicutt, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 4000 Johnson Rd, Steubenville, OH 43952 Phone: 740-264-8287 Fax: 740-264-8622 | |
William H Vaughan, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 4000 Johnson Rd, Steubenville, OH 43952 Phone: 740-264-8288 Fax: 740-264-8622 | |
Heung J Yoo, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 4000 Johnson Rd, Steubenville, OH 43952 Phone: 740-264-8288 Fax: 740-264-8622 | |
Jeffrey R Clark, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 4000 Johnson Rd, Steubenville, OH 43952 Phone: 740-264-8287 Fax: 740-264-8622 |